| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 6.50e-09 | 188 | 84 | 10 | GO:0005201 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 4.00e-08 | 120 | 84 | 8 | GO:0004222 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 5.10e-07 | 16 | 84 | 4 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.65e-06 | 21 | 84 | 4 | GO:0030228 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 2.00e-06 | 200 | 84 | 8 | GO:0008237 | |
| GeneOntologyMolecularFunction | zinc ion binding | MEP1A ZSWIM8 PDE2A ZMYND11 HIVEP1 DHX58 ADAMTS2 ADAMTS9 ZPR1 POLR2A MIB1 ADAMTS20 PAPPA ARIH1 RNF217 | 4.09e-06 | 891 | 84 | 15 | GO:0008270 |
| GeneOntologyMolecularFunction | GAF domain binding | 1.75e-05 | 2 | 84 | 2 | GO:0036004 | |
| GeneOntologyMolecularFunction | transition metal ion binding | MEP1A ZSWIM8 PDE2A ZMYND11 HIVEP1 DHX58 FN1 ADAMTS2 ADAMTS9 ZPR1 POLR2A MIB1 ADAMTS20 PAPPA ARIH1 RNF217 | 3.10e-05 | 1189 | 84 | 16 | GO:0046914 |
| GeneOntologyMolecularFunction | structural constituent of synapse-associated extracellular matrix | 5.23e-05 | 3 | 84 | 2 | GO:0150043 | |
| GeneOntologyMolecularFunction | RNA-dependent RNA polymerase activity | 5.23e-05 | 3 | 84 | 2 | GO:0003968 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 4.52e-04 | 430 | 84 | 8 | GO:0004175 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 4.55e-04 | 85 | 84 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | integrin binding | 8.62e-04 | 175 | 84 | 5 | GO:0005178 | |
| GeneOntologyMolecularFunction | RNA polymerase II activity | 9.38e-04 | 11 | 84 | 2 | GO:0001055 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 1.12e-03 | 12 | 84 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | calcium ion binding | 1.17e-03 | 749 | 84 | 10 | GO:0005509 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 1.54e-03 | 14 | 84 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 2.56e-03 | 18 | 84 | 2 | GO:0030169 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 3.16e-03 | 20 | 84 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 3.89e-03 | 152 | 84 | 4 | GO:0016779 | |
| GeneOntologyMolecularFunction | structural molecule activity | 4.14e-03 | 891 | 84 | 10 | GO:0005198 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | THSD4 COL7A1 ADAMTSL1 FN1 ADAMTS2 ADAMTS7 ADAMTS9 LRP1 ADAMTS20 LAMB1 LAMB2 PAPLN NOTCH1 | 2.96e-09 | 377 | 82 | 13 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | THSD4 COL7A1 ADAMTSL1 FN1 ADAMTS2 ADAMTS7 ADAMTS9 LRP1 ADAMTS20 LAMB1 LAMB2 PAPLN NOTCH1 | 3.05e-09 | 378 | 82 | 13 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | THSD4 COL7A1 ADAMTSL1 FN1 ADAMTS2 ADAMTS7 ADAMTS9 LRP1 ADAMTS20 LAMB1 LAMB2 PAPLN NOTCH1 | 3.15e-09 | 379 | 82 | 13 | GO:0045229 |
| GeneOntologyBiologicalProcess | RNA-templated transcription | 4.67e-05 | 3 | 82 | 2 | GO:0001172 | |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 8.94e-05 | 59 | 82 | 4 | GO:0085029 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 9.32e-05 | 4 | 82 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | axon extension involved in regeneration | 1.55e-04 | 5 | 82 | 2 | GO:0048677 | |
| GeneOntologyBiologicalProcess | positive regulation of melanocyte differentiation | 1.55e-04 | 5 | 82 | 2 | GO:0045636 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | 2.05e-04 | 515 | 82 | 9 | GO:0072594 | |
| GeneOntologyBiologicalProcess | sprouting of injured axon | 2.32e-04 | 6 | 82 | 2 | GO:0048682 | |
| GeneOntologyCellularComponent | extracellular matrix | THSD4 COL7A1 ADAMTSL1 FBN1 FCGBP FBN2 VWF FN1 ADAMTS2 ADAMTS7 ADAMTS9 OTOGL ITLN1 ADAMTS20 LAMB1 LAMB2 PAPLN CFP FBN3 | 1.04e-11 | 656 | 84 | 19 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | THSD4 COL7A1 ADAMTSL1 FBN1 FCGBP FBN2 VWF FN1 ADAMTS2 ADAMTS7 ADAMTS9 OTOGL ITLN1 ADAMTS20 LAMB1 LAMB2 PAPLN CFP FBN3 | 1.09e-11 | 658 | 84 | 19 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | THSD4 COL7A1 ADAMTSL1 FBN1 FBN2 VWF FN1 ADAMTS2 ADAMTS9 ITLN1 ADAMTS20 LAMB1 LAMB2 PAPLN CFP | 2.80e-09 | 530 | 84 | 15 | GO:0062023 |
| GeneOntologyCellularComponent | microfibril | 1.69e-07 | 13 | 84 | 4 | GO:0001527 | |
| GeneOntologyCellularComponent | basement membrane | 9.79e-06 | 122 | 84 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 5.69e-05 | 332 | 84 | 8 | GO:0005788 | |
| GeneOntologyCellularComponent | Cul3-RING ubiquitin ligase complex | 5.15e-04 | 39 | 84 | 3 | GO:0031463 | |
| GeneOntologyCellularComponent | laminin complex | 7.03e-04 | 10 | 84 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | RNA polymerase II, core complex | 2.09e-03 | 17 | 84 | 2 | GO:0005665 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 2.09e-03 | 17 | 84 | 2 | GO:0098637 | |
| MousePheno | fused cornea and lens | 3.72e-06 | 24 | 63 | 4 | MP:0001307 | |
| MousePheno | abnormal aortic sinus morphology | 2.00e-05 | 2 | 63 | 2 | MP:0010482 | |
| MousePheno | abnormal viscerocranium morphology | FBN1 FBN2 ADAMTS2 LRP4 AGAP7P AGAP4 AGAP6 NIPBL VWDE DISP1 AGAP1 | 6.03e-05 | 593 | 63 | 11 | MP:0005274 |
| MousePheno | abnormal craniofacial morphology | COL7A1 ZMYND11 FBN1 FBN2 ADAMTS2 MIB1 LRP1 LRP4 AGAP7P AGAP4 AGAP6 NIPBL VWDE DISP1 NOTCH1 AGAP1 SORL1 | 8.35e-05 | 1372 | 63 | 17 | MP:0000428 |
| MousePheno | craniofacial phenotype | COL7A1 ZMYND11 FBN1 FBN2 ADAMTS2 MIB1 LRP1 LRP4 AGAP7P AGAP4 AGAP6 NIPBL VWDE DISP1 NOTCH1 AGAP1 SORL1 | 8.35e-05 | 1372 | 63 | 17 | MP:0005382 |
| MousePheno | abnormal tooth morphology | 8.57e-05 | 318 | 63 | 8 | MP:0002100 | |
| MousePheno | abnormal dental arch morphology | 8.76e-05 | 319 | 63 | 8 | MP:0030254 | |
| MousePheno | distended pericardium | 1.08e-04 | 55 | 63 | 4 | MP:0000292 | |
| MousePheno | abnormal jaw morphology | 1.18e-04 | 530 | 63 | 10 | MP:0000454 | |
| MousePheno | abnormal snout morphology | 1.50e-04 | 257 | 63 | 7 | MP:0000443 | |
| MousePheno | abnormal skin coloration | 1.65e-04 | 182 | 63 | 6 | MP:0011239 | |
| MousePheno | failure of neuromuscular synapse postsynaptic differentiation | 2.96e-04 | 6 | 63 | 2 | MP:0001055 | |
| MousePheno | failure of neuromuscular synapse presynaptic differentiation | 2.96e-04 | 6 | 63 | 2 | MP:0001054 | |
| MousePheno | limbs/digits/tail phenotype | COL7A1 FBN1 FBN2 FN1 ADAMTS9 ITLN1 KBTBD8 LRP1 LRP4 ADAMTS20 LAMB1 PAPPA ARIH1 NIPBL DISP1 | 3.68e-04 | 1258 | 63 | 15 | MP:0005371 |
| MousePheno | increased total lung capacity | 4.14e-04 | 7 | 63 | 2 | MP:0010937 | |
| MousePheno | abnormal lens development | 4.16e-04 | 78 | 63 | 4 | MP:0005545 | |
| Domain | EGF-like_dom | MEP1A FBN1 FCGBP FBN2 TENM1 LRP1 LRP4 LAMB1 LAMB2 VWCE ADAM12 LRP1B VWDE FBN3 NOTCH1 SORL1 STAB1 | 4.61e-16 | 249 | 81 | 17 | IPR000742 |
| Domain | EGF-like_CS | MEP1A FBN1 FBN2 FN1 TENM1 LRP1 LRP4 LAMB1 LAMB2 VWCE ADAM12 LRP1B VWDE FBN3 NOTCH1 SORL1 STAB1 | 1.01e-15 | 261 | 81 | 17 | IPR013032 |
| Domain | EGF | MEP1A FBN1 FCGBP FBN2 TENM1 LRP1 LRP4 LAMB1 LAMB2 VWCE LRP1B VWDE FBN3 NOTCH1 SORL1 STAB1 | 3.84e-15 | 235 | 81 | 16 | SM00181 |
| Domain | EGF_1 | MEP1A FBN1 FBN2 FN1 TENM1 LRP1 LRP4 LAMB1 LAMB2 VWCE ADAM12 LRP1B VWDE FBN3 NOTCH1 STAB1 | 1.39e-14 | 255 | 81 | 16 | PS00022 |
| Domain | EGF_2 | MEP1A FBN1 FBN2 TENM1 LRP1 LRP4 LAMB1 LAMB2 VWCE ADAM12 LRP1B VWDE FBN3 NOTCH1 SORL1 STAB1 | 2.53e-14 | 265 | 81 | 16 | PS01186 |
| Domain | EGF_3 | MEP1A FBN1 FBN2 TENM1 LRP1 LRP4 VWCE ADAM12 LRP1B VWDE FBN3 NOTCH1 SORL1 STAB1 | 1.46e-12 | 235 | 81 | 14 | PS50026 |
| Domain | Growth_fac_rcpt_ | ERBB4 FBN1 FBN2 LRP1 LRP4 LAMB1 LAMB2 VWCE LRP1B FBN3 NOTCH1 STAB1 | 3.24e-12 | 156 | 81 | 12 | IPR009030 |
| Domain | TSP_1 | 2.81e-10 | 63 | 81 | 8 | PF00090 | |
| Domain | TSP1 | 3.63e-10 | 65 | 81 | 8 | SM00209 | |
| Domain | TSP1_rpt | 3.63e-10 | 65 | 81 | 8 | IPR000884 | |
| Domain | TSP1 | 3.63e-10 | 65 | 81 | 8 | PS50092 | |
| Domain | ADAM_spacer1 | 5.24e-10 | 23 | 81 | 6 | IPR010294 | |
| Domain | ADAM_spacer1 | 5.24e-10 | 23 | 81 | 6 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 6.97e-10 | 24 | 81 | 6 | IPR013273 | |
| Domain | cEGF | 1.18e-09 | 26 | 81 | 6 | IPR026823 | |
| Domain | cEGF | 1.18e-09 | 26 | 81 | 6 | PF12662 | |
| Domain | EGF_CA | 2.82e-09 | 122 | 81 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.26e-09 | 124 | 81 | 9 | IPR001881 | |
| Domain | EGF_CA | 3.55e-09 | 86 | 81 | 8 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 9.30e-09 | 97 | 81 | 8 | IPR018097 | |
| Domain | EGF_CA | 1.09e-08 | 99 | 81 | 8 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.18e-08 | 100 | 81 | 8 | PS00010 | |
| Domain | PLAC | 1.50e-08 | 19 | 81 | 5 | PS50900 | |
| Domain | PLAC | 1.50e-08 | 19 | 81 | 5 | IPR010909 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.88e-08 | 106 | 81 | 8 | IPR000152 | |
| Domain | MetalloPept_cat_dom | 5.95e-08 | 81 | 81 | 7 | IPR024079 | |
| Domain | - | 5.95e-08 | 81 | 81 | 7 | 3.40.390.10 | |
| Domain | FBN | 7.86e-08 | 3 | 81 | 3 | IPR011398 | |
| Domain | ZINC_PROTEASE | 2.23e-07 | 98 | 81 | 7 | PS00142 | |
| Domain | Ldl_recept_b | 3.18e-07 | 14 | 81 | 4 | PF00058 | |
| Domain | LDLRB | 3.18e-07 | 14 | 81 | 4 | PS51120 | |
| Domain | LY | 4.32e-07 | 15 | 81 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 4.32e-07 | 15 | 81 | 4 | IPR000033 | |
| Domain | Peptidase_M12B_N | 6.94e-07 | 39 | 81 | 5 | IPR002870 | |
| Domain | Pep_M12B_propep | 6.94e-07 | 39 | 81 | 5 | PF01562 | |
| Domain | - | 6.94e-07 | 39 | 81 | 5 | 2.120.10.30 | |
| Domain | DISINTEGRIN_1 | 7.91e-07 | 40 | 81 | 5 | PS00427 | |
| Domain | Reprolysin | 7.91e-07 | 40 | 81 | 5 | PF01421 | |
| Domain | ADAM_MEPRO | 7.91e-07 | 40 | 81 | 5 | PS50215 | |
| Domain | DISINTEGRIN_2 | 7.91e-07 | 40 | 81 | 5 | PS50214 | |
| Domain | Peptidase_M12B | 7.91e-07 | 40 | 81 | 5 | IPR001590 | |
| Domain | Disintegrin_dom | 8.98e-07 | 41 | 81 | 5 | IPR001762 | |
| Domain | EGF | 1.24e-06 | 126 | 81 | 7 | PF00008 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.61e-06 | 46 | 81 | 5 | IPR011042 | |
| Domain | TB | 2.72e-06 | 7 | 81 | 3 | PF00683 | |
| Domain | - | 4.33e-06 | 8 | 81 | 3 | 3.90.290.10 | |
| Domain | EGF_extracell | 6.13e-06 | 60 | 81 | 5 | IPR013111 | |
| Domain | EGF_2 | 6.13e-06 | 60 | 81 | 5 | PF07974 | |
| Domain | TB | 6.48e-06 | 9 | 81 | 3 | PS51364 | |
| Domain | TB_dom | 6.48e-06 | 9 | 81 | 3 | IPR017878 | |
| Domain | ArfGap | 7.18e-06 | 29 | 81 | 4 | SM00105 | |
| Domain | ArfGap | 7.18e-06 | 29 | 81 | 4 | PF01412 | |
| Domain | ARFGAP | 7.18e-06 | 29 | 81 | 4 | PS50115 | |
| Domain | ArfGAP | 7.18e-06 | 29 | 81 | 4 | IPR001164 | |
| Domain | Pept_M12B_GON-ADAMTSs | 1.86e-05 | 2 | 81 | 2 | IPR012314 | |
| Domain | GON | 1.86e-05 | 2 | 81 | 2 | PF08685 | |
| Domain | DUF5050 | 1.86e-05 | 2 | 81 | 2 | IPR032485 | |
| Domain | GON | 1.86e-05 | 2 | 81 | 2 | PS51046 | |
| Domain | DUF5050 | 1.86e-05 | 2 | 81 | 2 | PF16472 | |
| Domain | LDLR_class-A_CS | 2.66e-05 | 40 | 81 | 4 | IPR023415 | |
| Domain | PLAC | 2.76e-05 | 14 | 81 | 3 | PF08686 | |
| Domain | VWD | 4.23e-05 | 16 | 81 | 3 | SM00216 | |
| Domain | VWF_type-D | 4.23e-05 | 16 | 81 | 3 | IPR001846 | |
| Domain | VWFD | 4.23e-05 | 16 | 81 | 3 | PS51233 | |
| Domain | VWD | 4.23e-05 | 16 | 81 | 3 | PF00094 | |
| Domain | Ldl_recept_a | 4.27e-05 | 45 | 81 | 4 | PF00057 | |
| Domain | - | 4.66e-05 | 46 | 81 | 4 | 4.10.400.10 | |
| Domain | LDLRA_1 | 5.52e-05 | 48 | 81 | 4 | PS01209 | |
| Domain | LAMININ_IVB | 5.56e-05 | 3 | 81 | 2 | PS51116 | |
| Domain | Laminin_IV_B | 5.56e-05 | 3 | 81 | 2 | IPR013015 | |
| Domain | LDLRA_2 | 6.00e-05 | 49 | 81 | 4 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 6.00e-05 | 49 | 81 | 4 | IPR002172 | |
| Domain | LDLa | 6.00e-05 | 49 | 81 | 4 | SM00192 | |
| Domain | VWC_out | 7.24e-05 | 19 | 81 | 3 | SM00215 | |
| Domain | hEGF | 2.38e-04 | 28 | 81 | 3 | PF12661 | |
| Domain | EGF_LAM_2 | 2.93e-04 | 30 | 81 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 2.93e-04 | 30 | 81 | 3 | PS01248 | |
| Domain | Notch_dom | 3.85e-04 | 7 | 81 | 2 | IPR000800 | |
| Domain | Notch | 3.85e-04 | 7 | 81 | 2 | PF00066 | |
| Domain | NL | 3.85e-04 | 7 | 81 | 2 | SM00004 | |
| Domain | Laminin_EGF | 4.65e-04 | 35 | 81 | 3 | PF00053 | |
| Domain | EGF_Lam | 4.65e-04 | 35 | 81 | 3 | SM00180 | |
| Domain | VWC | 5.94e-04 | 38 | 81 | 3 | SM00214 | |
| Domain | Laminin_EGF | 5.94e-04 | 38 | 81 | 3 | IPR002049 | |
| Domain | GAF_dom-like | 6.56e-04 | 9 | 81 | 2 | IPR029016 | |
| Domain | - | 6.56e-04 | 9 | 81 | 2 | 3.30.450.40 | |
| Domain | ANK | 7.76e-04 | 251 | 81 | 6 | SM00248 | |
| Domain | VWF_dom | 7.99e-04 | 42 | 81 | 3 | IPR001007 | |
| Domain | ANK_REPEAT | 8.09e-04 | 253 | 81 | 6 | PS50088 | |
| Domain | E3_UB_ligase_RBR | 8.17e-04 | 10 | 81 | 2 | IPR031127 | |
| Domain | Ankyrin_rpt-contain_dom | 8.26e-04 | 254 | 81 | 6 | IPR020683 | |
| Domain | ANK_REP_REGION | 8.26e-04 | 254 | 81 | 6 | PS50297 | |
| Domain | Ankyrin_rpt | 9.70e-04 | 262 | 81 | 6 | IPR002110 | |
| Domain | TIL | 1.19e-03 | 12 | 81 | 2 | PF01826 | |
| Domain | C8 | 1.19e-03 | 12 | 81 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 1.40e-03 | 13 | 81 | 2 | IPR014853 | |
| Domain | C8 | 1.40e-03 | 13 | 81 | 2 | SM00832 | |
| Domain | IBR | 1.63e-03 | 14 | 81 | 2 | SM00647 | |
| Domain | TIL_dom | 1.63e-03 | 14 | 81 | 2 | IPR002919 | |
| Domain | IBR | 1.63e-03 | 14 | 81 | 2 | PF01485 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.16e-10 | 39 | 59 | 7 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.16e-10 | 39 | 59 | 7 | MM15165 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.50e-10 | 68 | 59 | 8 | M27303 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL7A1 FBN1 FBN2 VWF FN1 ADAMTS2 ADAMTS9 LRP4 LAMB1 LAMB2 ADAM12 FBN3 | 3.17e-09 | 300 | 59 | 12 | M610 |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | THSD4 ADAMTSL1 GNE ADAMTS2 ADAMTS7 ADAMTS9 ADAMTS20 CFP NOTCH1 | 7.21e-09 | 143 | 59 | 9 | M27275 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.33e-07 | 109 | 59 | 7 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.78e-07 | 111 | 59 | 7 | M27416 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | THSD4 ADAMTSL1 GNE ADAMTS2 ADAMTS7 ADAMTS9 ADAMTS20 CFP NOTCH1 | 8.72e-07 | 250 | 59 | 9 | M27554 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.82e-06 | 140 | 59 | 7 | M587 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 7.94e-06 | 66 | 59 | 5 | M18 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.65e-05 | 37 | 59 | 4 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.32e-05 | 44 | 59 | 4 | M26969 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 9.60e-05 | 258 | 59 | 7 | MM14572 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 1.50e-04 | 25 | 59 | 3 | M39713 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 1.66e-04 | 124 | 59 | 5 | M27285 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.61e-04 | 30 | 59 | 3 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.61e-04 | 30 | 59 | 3 | M27216 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 2.61e-04 | 30 | 59 | 3 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 2.61e-04 | 30 | 59 | 3 | MM15812 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.84e-04 | 76 | 59 | 4 | M27219 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.84e-04 | 76 | 59 | 4 | MM14867 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.17e-04 | 32 | 59 | 3 | MM14854 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 4.16e-04 | 84 | 59 | 4 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.35e-04 | 85 | 59 | 4 | M16441 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 5.72e-04 | 39 | 59 | 3 | MM14601 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 6.63e-04 | 41 | 59 | 3 | M27778 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 7.63e-04 | 43 | 59 | 3 | M53 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | THSD4 COL7A1 ADAMTSL1 FBN1 DPH5 FN1 GNE ADAMTS2 ADAMTS7 ADAMTS9 KBTBD8 ADAMTS20 LAMB1 LAMB2 CFP | 8.58e-04 | 1475 | 59 | 15 | M19806 |
| Pathway | PID_INTEGRIN4_PATHWAY | 9.24e-04 | 11 | 59 | 2 | M158 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.31e-03 | 114 | 59 | 4 | MM14571 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 1.75e-03 | 15 | 59 | 2 | M12101 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 1.75e-03 | 15 | 59 | 2 | M1262 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 1.75e-03 | 15 | 59 | 2 | MM14959 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 1.75e-03 | 15 | 59 | 2 | M27202 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 1.75e-03 | 15 | 59 | 2 | MM14961 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.92e-03 | 59 | 59 | 3 | M27218 | |
| Pathway | PID_NOTCH_PATHWAY | 1.92e-03 | 59 | 59 | 3 | M17 | |
| Pathway | PID_INTEGRIN5_PATHWAY | 2.25e-03 | 17 | 59 | 2 | M212 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 2.31e-03 | 63 | 59 | 3 | MM15613 | |
| Pathway | REACTOME_FGFR2_ALTERNATIVE_SPLICING | 2.52e-03 | 18 | 59 | 2 | MM15334 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR2_IIIA_TM | 2.81e-03 | 19 | 59 | 2 | M27739 | |
| Pubmed | THAP4 ZSWIM8 PDE2A FBN1 VWF FN1 ADAMTS9 EIF4A2 LRSAM1 MIB1 LRP1 ZBTB47 LRP4 LAMB1 AIP ZNF439 DNAJA1 LRP1B NIPBL DSCAML1 TXNDC11 AGAP1 STAB1 | 3.62e-14 | 1285 | 85 | 23 | 35914814 | |
| Pubmed | 3.46e-13 | 118 | 85 | 10 | 21078624 | ||
| Pubmed | 1.34e-11 | 75 | 85 | 8 | 20637190 | ||
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 3.32e-11 | 4 | 85 | 4 | 25034023 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 1.65e-10 | 219 | 85 | 10 | 31353912 | |
| Pubmed | 3.29e-10 | 167 | 85 | 9 | 22159717 | ||
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 4.15e-09 | 9 | 85 | 4 | 12640130 | |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 6.90e-09 | 10 | 85 | 4 | 20664521 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.06e-08 | 248 | 85 | 9 | 24006456 | |
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 1.08e-08 | 11 | 85 | 4 | 15381706 | |
| Pubmed | 1.19e-08 | 64 | 85 | 6 | 22261194 | ||
| Pubmed | 1.21e-08 | 175 | 85 | 8 | 28071719 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | ZSWIM8 HIVEP1 FBN1 VWF FN1 LRSAM1 LAMB2 AGAP7P VWCE ADAM12 NOTCH1 STAB1 | 1.22e-08 | 560 | 85 | 12 | 21653829 |
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 1.62e-08 | 12 | 85 | 4 | 25770910 | |
| Pubmed | 2.34e-08 | 13 | 85 | 4 | 27713690 | ||
| Pubmed | 3.26e-08 | 14 | 85 | 4 | 15082773 | ||
| Pubmed | 3.26e-08 | 14 | 85 | 4 | 22453919 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 4.35e-08 | 135 | 85 | 7 | 28675934 | |
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 9.90e-08 | 18 | 85 | 4 | 39040056 | |
| Pubmed | 1.03e-07 | 153 | 85 | 7 | 25037231 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 19047013 | ||
| Pubmed | Laminin-10 and Lutheran blood group glycoproteins in adhesion of human endothelial cells. | 2.80e-07 | 6 | 85 | 3 | 16236823 | |
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 20874775 | ||
| Pubmed | 2.84e-07 | 23 | 85 | 4 | 26027930 | ||
| Pubmed | 4.26e-07 | 116 | 85 | 6 | 30652415 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 4.77e-07 | 26 | 85 | 4 | 34189436 | |
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 11891225 | ||
| Pubmed | 7.53e-07 | 29 | 85 | 4 | 22613833 | ||
| Pubmed | Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis. | 7.82e-07 | 8 | 85 | 3 | 23055981 | |
| Pubmed | Semaphorin 3E/PlexinD1 signaling is required for cardiac ventricular compaction. | 1.13e-06 | 32 | 85 | 4 | 31434798 | |
| Pubmed | 1.17e-06 | 9 | 85 | 3 | 12122015 | ||
| Pubmed | 1.17e-06 | 9 | 85 | 3 | 38844137 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 1.51e-06 | 79 | 85 | 5 | 18757743 | |
| Pubmed | 1.67e-06 | 10 | 85 | 3 | 30738849 | ||
| Pubmed | 1.67e-06 | 10 | 85 | 3 | 11167130 | ||
| Pubmed | Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice. | 2.06e-06 | 37 | 85 | 4 | 34323105 | |
| Pubmed | 2.29e-06 | 11 | 85 | 3 | 24639464 | ||
| Pubmed | FBN2 POLR2B LRP1 LAMB1 LAMB2 ARIH1 DNAJA1 VWDE TXNDC11 SORL1 | 2.57e-06 | 613 | 85 | 10 | 22268729 | |
| Pubmed | 3.05e-06 | 12 | 85 | 3 | 26405179 | ||
| Pubmed | ZSWIM8 ERBB4 ZMYND11 FBN2 ATXN7L2 ZNF618 POLR2A POLR2B LRP1 LRP4 LAMB1 DNAJA1 SORL1 | 3.10e-06 | 1116 | 85 | 13 | 31753913 | |
| Pubmed | Impaired ADAMTS9 secretion: A potential mechanism for eye defects in Peters Plus Syndrome. | 5.03e-06 | 14 | 85 | 3 | 27687499 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 5.10e-06 | 101 | 85 | 5 | 23382219 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 12399449 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 21851253 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 19037100 | ||
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 5.90e-06 | 2 | 85 | 2 | 15963947 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 7963647 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 5.90e-06 | 2 | 85 | 2 | 30044367 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 5.90e-06 | 2 | 85 | 2 | 21440062 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 15131124 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 17584298 | ||
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 5.90e-06 | 2 | 85 | 2 | 20404337 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 34968453 | ||
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 5.90e-06 | 2 | 85 | 2 | 8791520 | |
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 5.90e-06 | 2 | 85 | 2 | 8307578 | |
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 5.90e-06 | 2 | 85 | 2 | 7744963 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 26408953 | ||
| Pubmed | The C-terminal region of laminin beta chains modulates the integrin binding affinities of laminins. | 5.90e-06 | 2 | 85 | 2 | 19147489 | |
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 5.90e-06 | 2 | 85 | 2 | 18006876 | |
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 5.90e-06 | 2 | 85 | 2 | 24833718 | |
| Pubmed | Exome sequencing identified new mutations in a Marfan syndrome family. | 5.90e-06 | 2 | 85 | 2 | 24484584 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 21880733 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 24265020 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 20529844 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 23133647 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 21876163 | ||
| Pubmed | Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. | 5.90e-06 | 2 | 85 | 2 | 1852206 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 12429739 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 21570975 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 19734141 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 35141985 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 2179554 | ||
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 5.90e-06 | 2 | 85 | 2 | 12524050 | |
| Pubmed | Three-dimensional visualization of extracellular matrix networks during murine development. | 5.90e-06 | 2 | 85 | 2 | 29352963 | |
| Pubmed | Metalloprotease-disintegrin ADAM12 expression is regulated by Notch signaling via microRNA-29. | 5.90e-06 | 2 | 85 | 2 | 21518768 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 8120105 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 35419902 | ||
| Pubmed | Fibrillin assembly: dimer formation mediated by amino-terminal sequences. | 5.90e-06 | 2 | 85 | 2 | 10504303 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 15221638 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 22782528 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 11867643 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 12514189 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 23395899 | ||
| Pubmed | Fibrillin-1 microfibril deposition is dependent on fibronectin assembly. | 5.90e-06 | 2 | 85 | 2 | 18653538 | |
| Pubmed | LRP1 is required for novobiocin-mediated fibronectin turnover. | 5.90e-06 | 2 | 85 | 2 | 30061663 | |
| Pubmed | Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development. | 5.90e-06 | 2 | 85 | 2 | 25524144 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 29599141 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 26697810 | ||
| Pubmed | Fibrillins 1 and 2 perform partially overlapping functions during aortic development. | 5.90e-06 | 2 | 85 | 2 | 16407178 | |
| Pubmed | Complex contributions of fibronectin to initiation and maturation of microfibrils. | 5.90e-06 | 2 | 85 | 2 | 24070235 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 19940141 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 10359653 | ||
| Pubmed | Plasma fibronectin supports hemostasis and regulates thrombosis. | 5.90e-06 | 2 | 85 | 2 | 25180602 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | COL7A1 FBN1 FBN2 LRP1 LRP4 LAMB1 LAMB2 AIP ADAM12 LRP1B NOTCH1 TXNDC11 SORL1 | 6.85e-06 | 1201 | 85 | 13 | 35696571 |
| Pubmed | 7.02e-06 | 50 | 85 | 4 | 23658023 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 8.46e-06 | 552 | 85 | 9 | 10737800 | |
| Pubmed | 9.35e-06 | 17 | 85 | 3 | 22183742 | ||
| Pubmed | 9.35e-06 | 17 | 85 | 3 | 18082680 | ||
| Pubmed | TGF-beta-1 up-regulates extra-cellular matrix production in mouse hepatoblasts. | 1.12e-05 | 18 | 85 | 3 | 23041440 | |
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 1.12e-05 | 18 | 85 | 3 | 35503090 | |
| Interaction | IGFL3 interactions | FBN2 ADAMTS2 ADAMTS7 LRP4 LAMB1 LAMB2 LRP1B VWDE NOTCH1 SORL1 | 5.35e-13 | 75 | 83 | 10 | int:IGFL3 |
| Interaction | NTN5 interactions | 5.08e-12 | 24 | 83 | 7 | int:NTN5 | |
| Interaction | CFC1 interactions | 2.43e-09 | 126 | 83 | 9 | int:CFC1 | |
| Interaction | ZFP41 interactions | 3.48e-09 | 57 | 83 | 7 | int:ZFP41 | |
| Interaction | ATXN7 interactions | 1.59e-08 | 109 | 83 | 8 | int:ATXN7 | |
| Interaction | ZNF74 interactions | 2.66e-07 | 34 | 83 | 5 | int:ZNF74 | |
| Interaction | PRG2 interactions | THSD4 ZSWIM8 FBN2 ADAMTS2 ADAMTS7 LAMB2 PAPPA VWDE NOTCH1 SORL1 | 2.68e-07 | 285 | 83 | 10 | int:PRG2 |
| Interaction | FBXO2 interactions | THSD4 FBN1 FBN2 FN1 ADAMTS7 LAMB1 LAMB2 LRP1B NOTCH1 TXNDC11 SORL1 | 9.60e-07 | 411 | 83 | 11 | int:FBXO2 |
| Interaction | ZNF224 interactions | 1.23e-06 | 20 | 83 | 4 | int:ZNF224 | |
| Interaction | WDR76 interactions | 3.87e-06 | 383 | 83 | 10 | int:WDR76 | |
| Interaction | ANKRD36B interactions | 4.80e-06 | 60 | 83 | 5 | int:ANKRD36B | |
| Interaction | EDN3 interactions | 5.56e-06 | 108 | 83 | 6 | int:EDN3 | |
| Interaction | SDF2L1 interactions | 7.07e-06 | 322 | 83 | 9 | int:SDF2L1 | |
| Interaction | FST interactions | 8.81e-06 | 32 | 83 | 4 | int:FST | |
| Interaction | MSTN interactions | 9.99e-06 | 33 | 83 | 4 | int:MSTN | |
| Interaction | DUSP10 interactions | 1.10e-05 | 71 | 83 | 5 | int:DUSP10 | |
| Interaction | NDP interactions | 1.27e-05 | 35 | 83 | 4 | int:NDP | |
| Interaction | BCAN interactions | 1.42e-05 | 36 | 83 | 4 | int:BCAN | |
| Interaction | ZNF563 interactions | 1.44e-05 | 12 | 83 | 3 | int:ZNF563 | |
| Interaction | HOXA1 interactions | 1.58e-05 | 356 | 83 | 9 | int:HOXA1 | |
| Interaction | GREM2 interactions | 1.59e-05 | 37 | 83 | 4 | int:GREM2 | |
| Interaction | VEGFD interactions | 1.77e-05 | 38 | 83 | 4 | int:VEGFD | |
| Interaction | LYPD6B interactions | 1.97e-05 | 39 | 83 | 4 | int:LYPD6B | |
| Interaction | LYZL2 interactions | 2.66e-05 | 85 | 83 | 5 | int:LYZL2 | |
| Interaction | SIRPD interactions | 2.81e-05 | 86 | 83 | 5 | int:SIRPD | |
| Interaction | SLURP1 interactions | 2.88e-05 | 144 | 83 | 6 | int:SLURP1 | |
| Interaction | ZNF408 interactions | 2.99e-05 | 145 | 83 | 6 | int:ZNF408 | |
| Interaction | DEFB123 interactions | 3.63e-05 | 16 | 83 | 3 | int:DEFB123 | |
| Interaction | ELSPBP1 interactions | 3.90e-05 | 92 | 83 | 5 | int:ELSPBP1 | |
| Interaction | RLN1 interactions | 4.10e-05 | 93 | 83 | 5 | int:RLN1 | |
| Interaction | C3 interactions | 4.35e-05 | 155 | 83 | 6 | int:C3 | |
| Interaction | DKK2 interactions | 4.92e-05 | 49 | 83 | 4 | int:DKK2 | |
| Interaction | FOXD4L6 interactions | 4.92e-05 | 49 | 83 | 4 | int:FOXD4L6 | |
| Interaction | SNAR-B2 interactions | 5.01e-05 | 3 | 83 | 2 | int:SNAR-B2 | |
| Interaction | CCN6 interactions | 6.22e-05 | 19 | 83 | 3 | int:CCN6 | |
| Interaction | MFAP5 interactions | 6.23e-05 | 52 | 83 | 4 | int:MFAP5 | |
| Interaction | DYRK1A interactions | FBN1 FN1 ADAMTS9 LRP4 LAMB1 LRP1B DSCAML1 AARSD1 AGAP1 STAB1 | 8.86e-05 | 552 | 83 | 10 | int:DYRK1A |
| Interaction | EN1 interactions | 9.15e-05 | 110 | 83 | 5 | int:EN1 | |
| Interaction | KLK3 interactions | 1.09e-04 | 60 | 83 | 4 | int:KLK3 | |
| Interaction | LAMA5 interactions | 1.22e-04 | 117 | 83 | 5 | int:LAMA5 | |
| Interaction | HRG interactions | 1.32e-04 | 63 | 83 | 4 | int:HRG | |
| Interaction | FBN2 interactions | 1.50e-04 | 65 | 83 | 4 | int:FBN2 | |
| Interaction | LYPD4 interactions | 1.55e-04 | 123 | 83 | 5 | int:LYPD4 | |
| Interaction | CACNA1A interactions | 1.55e-04 | 123 | 83 | 5 | int:CACNA1A | |
| Interaction | FBLN2 interactions | 1.59e-04 | 66 | 83 | 4 | int:FBLN2 | |
| Interaction | FBXO6 interactions | FBN2 ADAMTS7 POLR2B LRP1 LAMB1 LAMB2 ARIH1 DNAJA1 VWDE TXNDC11 SORL1 | 1.68e-04 | 717 | 83 | 11 | int:FBXO6 |
| Interaction | CDHR4 interactions | 1.78e-04 | 68 | 83 | 4 | int:CDHR4 | |
| Interaction | NTF3 interactions | 1.83e-04 | 27 | 83 | 3 | int:NTF3 | |
| Interaction | FEZF1 interactions | 2.05e-04 | 28 | 83 | 3 | int:FEZF1 | |
| Interaction | TAFAZZIN interactions | 2.14e-04 | 207 | 83 | 6 | int:TAFAZZIN | |
| Interaction | DLL4 interactions | 2.49e-04 | 6 | 83 | 2 | int:DLL4 | |
| Interaction | MFAP4 interactions | 2.74e-04 | 139 | 83 | 5 | int:MFAP4 | |
| Interaction | EGFL7 interactions | 2.88e-04 | 77 | 83 | 4 | int:EGFL7 | |
| Interaction | TAFA3 interactions | 3.03e-04 | 78 | 83 | 4 | int:TAFA3 | |
| Interaction | PI15 interactions | 3.84e-04 | 83 | 83 | 4 | int:PI15 | |
| Interaction | SOST interactions | 4.01e-04 | 35 | 83 | 3 | int:SOST | |
| Interaction | LIMK2 interactions | 4.02e-04 | 84 | 83 | 4 | int:LIMK2 | |
| Interaction | RMC1 interactions | 4.13e-04 | 152 | 83 | 5 | int:RMC1 | |
| Interaction | B3GLCT interactions | 4.36e-04 | 36 | 83 | 3 | int:B3GLCT | |
| Interaction | NID2 interactions | 4.39e-04 | 86 | 83 | 4 | int:NID2 | |
| Interaction | ORC5 interactions | 4.59e-04 | 87 | 83 | 4 | int:ORC5 | |
| Interaction | LCOR interactions | 4.92e-04 | 242 | 83 | 6 | int:LCOR | |
| Interaction | TIMP3 interactions | 5.22e-04 | 90 | 83 | 4 | int:TIMP3 | |
| Interaction | LTBP1 interactions | 5.67e-04 | 92 | 83 | 4 | int:LTBP1 | |
| Interaction | FSTL3 interactions | 5.92e-04 | 9 | 83 | 2 | int:FSTL3 | |
| Interaction | CCN2 interactions | 5.96e-04 | 40 | 83 | 3 | int:CCN2 | |
| Interaction | TAB1 interactions | 6.08e-04 | 252 | 83 | 6 | int:TAB1 | |
| Interaction | PRKD2 interactions | 6.34e-04 | 254 | 83 | 6 | int:PRKD2 | |
| Interaction | CTSG interactions | 6.40e-04 | 95 | 83 | 4 | int:CTSG | |
| Interaction | IGFBP4 interactions | 6.41e-04 | 41 | 83 | 3 | int:IGFBP4 | |
| Interaction | DEFB135 interactions | 6.89e-04 | 42 | 83 | 3 | int:DEFB135 | |
| Cytoband | 9q34.3 | 1.03e-03 | 106 | 85 | 3 | 9q34.3 | |
| Cytoband | 10p14 | 1.07e-03 | 26 | 85 | 2 | 10p14 | |
| Cytoband | 7q32.1 | 1.52e-03 | 31 | 85 | 2 | 7q32.1 | |
| Cytoband | 10q11.23 | 1.72e-03 | 33 | 85 | 2 | 10q11.23 | |
| Cytoband | 3p21.1 | 2.78e-03 | 42 | 85 | 2 | 3p21.1 | |
| Cytoband | 15q23 | 3.05e-03 | 44 | 85 | 2 | 15q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 3.18e-03 | 325 | 85 | 4 | chr9q34 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 3.56e-07 | 19 | 58 | 4 | 50 | |
| GeneFamily | ADAMTS like | 1.09e-06 | 7 | 58 | 3 | 947 | |
| GeneFamily | ArfGAPs | 3.64e-06 | 33 | 58 | 4 | 395 | |
| GeneFamily | Low density lipoprotein receptors | 8.76e-06 | 13 | 58 | 3 | 634 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 2.06e-05 | 17 | 58 | 3 | 1291 | |
| GeneFamily | Ankyrin repeat domain containing | 1.22e-04 | 242 | 58 | 6 | 403 | |
| GeneFamily | Laminin subunits | 6.54e-04 | 12 | 58 | 2 | 626 | |
| GeneFamily | Fibronectin type III domain containing | 1.73e-03 | 160 | 58 | 4 | 555 | |
| GeneFamily | RNA polymerase subunits | 3.88e-03 | 29 | 58 | 2 | 726 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.30e-03 | 206 | 58 | 4 | 682 | |
| GeneFamily | Complement system|Sushi domain containing | 5.94e-03 | 36 | 58 | 2 | 492 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 9.13e-03 | 134 | 58 | 3 | 861 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.50e-02 | 161 | 58 | 3 | 593 | |
| Coexpression | NABA_MATRISOME | MEP1A THSD4 COL7A1 ADAMTSL1 FBN1 FBN2 VWF FN1 ADAMTS2 ADAMTS7 ADAMTS9 OTOGL ITLN1 ADAMTS20 LAMB1 LAMB2 PAPPA PAPLN VWCE ADAM12 VWDE | 6.58e-12 | 1008 | 85 | 21 | MM17056 |
| Coexpression | NABA_MATRISOME | MEP1A THSD4 COL7A1 ADAMTSL1 FBN1 FBN2 VWF FN1 ADAMTS2 ADAMTS7 ADAMTS9 ITLN1 ADAMTS20 LAMB1 LAMB2 PAPPA PAPLN VWCE ADAM12 VWDE FBN3 | 9.17e-12 | 1026 | 85 | 21 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.07e-11 | 191 | 85 | 11 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.06e-11 | 196 | 85 | 11 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | THSD4 COL7A1 FBN1 FBN2 VWF FN1 OTOGL LAMB1 LAMB2 PAPLN VWCE VWDE | 7.55e-11 | 270 | 85 | 12 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | THSD4 COL7A1 FBN1 FBN2 VWF FN1 LAMB1 LAMB2 PAPLN VWCE VWDE FBN3 | 9.33e-11 | 275 | 85 | 12 | M5884 |
| Coexpression | THEODOROU_MAMMARY_TUMORIGENESIS | 2.08e-09 | 37 | 85 | 6 | MM1121 | |
| Coexpression | NABA_ECM_REGULATORS | MEP1A ADAMTSL1 ADAMTS2 ADAMTS7 ADAMTS9 ADAMTS20 PAPPA ADAM12 | 1.08e-06 | 238 | 85 | 8 | M3468 |
| Coexpression | NABA_ECM_REGULATORS | MEP1A ADAMTSL1 ADAMTS2 ADAMTS7 ADAMTS9 ADAMTS20 PAPPA ADAM12 | 1.23e-06 | 242 | 85 | 8 | MM17062 |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_3_DN | 9.01e-06 | 226 | 85 | 7 | M11238 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN | 1.27e-05 | 44 | 85 | 4 | MM485 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 2.17e-05 | 17 | 85 | 3 | M47995 | |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 2.53e-05 | 178 | 85 | 6 | M17079 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN | LDHD VWF FN1 ADAMTS7 TENM1 LRP1 ADAM12 DSCAML1 AGAP1 SORL1 STAB1 | 2.69e-05 | 740 | 85 | 11 | M41202 |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN | 4.72e-05 | 199 | 85 | 6 | M5219 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_DN | 4.85e-05 | 200 | 85 | 6 | M9657 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 4.85e-05 | 200 | 85 | 6 | M5930 | |
| Coexpression | DESCARTES_MAIN_FETAL_STELLATE_CELLS | 5.30e-05 | 63 | 85 | 4 | M40119 | |
| Coexpression | KARLSSON_TGFB1_TARGETS_DN | 6.19e-05 | 209 | 85 | 6 | MM1058 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 7.58e-05 | 69 | 85 | 4 | M10165 | |
| Coexpression | HALLMARK_COAGULATION | 8.80e-05 | 138 | 85 | 5 | M5946 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP | 9.10e-05 | 27 | 85 | 3 | M40935 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 9.10e-05 | 27 | 85 | 3 | M47994 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 9.97e-05 | 74 | 85 | 4 | M13547 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 1.14e-04 | 337 | 85 | 7 | MM16606 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 1.32e-04 | 240 | 85 | 6 | M39236 | |
| Coexpression | THEODOROU_MAMMARY_TUMORIGENESIS | 1.39e-04 | 31 | 85 | 3 | M1291 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 1.55e-04 | 6 | 85 | 2 | M48000 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 2.81e-04 | 276 | 85 | 6 | M3063 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 2.98e-04 | 40 | 85 | 3 | M5887 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.33e-06 | 261 | 83 | 8 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 | THSD4 LDHD ADAMTSL1 FBN1 FBN2 FN1 ZNF618 TLE2 SELENOO LRP1 ZBTB47 LRP4 LAMB2 PAPPA AIP TRAPPC14 | 1.86e-05 | 1228 | 83 | 16 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 2.51e-05 | 148 | 83 | 6 | gudmap_kidney_P3_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | COL7A1 ADAMTSL1 FBN1 FBN2 VWF CDC42BPA FN1 ADAMTS2 ADAMTS7 TLE2 LRP1 PAPPA CFP RNF217 STAB1 | 6.13e-05 | 1208 | 83 | 15 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.35e-04 | 288 | 83 | 7 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_500 | 1.41e-04 | 127 | 83 | 5 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k2_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480lo.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 1.82e-04 | 72 | 83 | 4 | GSM605859_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | ERBB4 FBN1 FBN2 FN1 ADAMTS2 ADAMTS9 LRP1 LAMB1 PAPPA C3AR1 ADAM12 | 2.05e-04 | 773 | 83 | 11 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | ADAMTSL1 FBN1 FBN2 FN1 ADAMTS2 ADAMTS9 ZNF618 LRP1 LAMB1 ADAM12 AARSD1 | 2.15e-04 | 777 | 83 | 11 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | Myeloid Cells, DC.II+480lo.PC, F4/80lo MHC II+ CD11c+ CD115+, Peritoneal Cavity, avg-3 | 2.36e-04 | 77 | 83 | 4 | GSM854294_100 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480int.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 2.74e-04 | 80 | 83 | 4 | GSM605856_100 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480int.PC, CD115+ MHCII- F480int SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 2.87e-04 | 81 | 83 | 4 | GSM605865_100 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 3.19e-04 | 439 | 83 | 8 | GSM777059_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480hi.PC, CD115+ MHC II- F480hi Siglec F-, Peritoneal Cavity, avg-3 | 3.30e-04 | 84 | 83 | 4 | GSM605862_100 | |
| CoexpressionAtlas | Myeloid Cells, MF.II-480hi.PC, F4/80hi CD115hi CD11b+ MHC II- CD11c-, Peritoneal Cavity, avg-3 | 3.61e-04 | 86 | 83 | 4 | GSM605850_100 | |
| ToppCell | mLN-(4)_Monocyte|mLN / shred on region, Cell_type, and subtype | 4.57e-09 | 199 | 85 | 8 | 6795ff31f92580195c9db776951f99d647484d24 | |
| ToppCell | mLN-Monocyte|mLN / Region, Cell class and subclass | 4.57e-09 | 199 | 85 | 8 | 241f790cd5d8a9b2451333deecc826a673bae70a | |
| ToppCell | mLN-Monocyte-Monocyte|mLN / Region, Cell class and subclass | 4.57e-09 | 199 | 85 | 8 | dcee372774c169a3048bdaed3734b3215bf8ffad | |
| ToppCell | mLN-(4)_Monocyte-(40)_Monocyte|mLN / shred on region, Cell_type, and subtype | 4.57e-09 | 199 | 85 | 8 | bcbb1eee8d79bf670dbe113094c3a292b135ce2f | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.76e-09 | 200 | 85 | 8 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.59e-08 | 169 | 85 | 7 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 5.13e-08 | 178 | 85 | 7 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.54e-08 | 180 | 85 | 7 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.54e-08 | 180 | 85 | 7 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.20e-08 | 183 | 85 | 7 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.20e-08 | 183 | 85 | 7 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.20e-08 | 183 | 85 | 7 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic|GI_large-bowel / Manually curated celltypes from each tissue | 7.45e-08 | 188 | 85 | 7 | d0045fdda757d191dabc7853f6a6e99c0e97d93d | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic-Classical_monocytes|GI_large-bowel / Manually curated celltypes from each tissue | 7.45e-08 | 188 | 85 | 7 | 0bcf04aa47738f43c1a87dae5dc487738ee86f8c | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 8.61e-08 | 192 | 85 | 7 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 9.24e-08 | 194 | 85 | 7 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.10e-07 | 199 | 85 | 7 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-07 | 200 | 85 | 7 | 3dacd0afe69bc16bb33336ea9ea99a9cd47731d9 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.64e-07 | 165 | 85 | 6 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.64e-07 | 165 | 85 | 6 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.64e-07 | 165 | 85 | 6 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.10e-07 | 170 | 85 | 6 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.74e-07 | 172 | 85 | 6 | c84cab89c97d647b8a256fd08e33d9102810febd | |
| ToppCell | Endothelial-Endothelial-G|Endothelial / shred on cell class and cell subclass (v4) | 9.74e-07 | 172 | 85 | 6 | 644f8e42ee8d8996f6ae50cdf874559be55509fc | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-06 | 178 | 85 | 6 | cc0382b0ee1e6c76522e2c86ad1425c45debab5d | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac-Erythrophagocytic_macrophages|bone_marrow / Manually curated celltypes from each tissue | 1.27e-06 | 180 | 85 | 6 | daf69a548ed7c6f285a6adcff00f99aa22f9d6a5 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.31e-06 | 181 | 85 | 6 | 47dce04db3392333eb2f7b9b24c32e6740d2d02f | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.31e-06 | 181 | 85 | 6 | 19103221c3a5a16b16378348004b2c50caee4f01 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.31e-06 | 181 | 85 | 6 | 091e7975badd1ffa463a8ec87908be20781ecfd6 | |
| ToppCell | P28-Mesenchymal|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.35e-06 | 182 | 85 | 6 | 69f9d44694fe4f55a971ae0ac5dc3e7448ee78f3 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-06 | 184 | 85 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-06 | 184 | 85 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-06 | 184 | 85 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | (0)_MSCs|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.54e-06 | 186 | 85 | 6 | a832c1e0035bcd559722eccf262c145deb3494c7 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.54e-06 | 186 | 85 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | (0)_MSCs-(00)_Lepr-MSC|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.54e-06 | 186 | 85 | 6 | f0d156167d7cc2cd8a76e5a364233e9f2170bc01 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-06 | 187 | 85 | 6 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-06 | 187 | 85 | 6 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-06 | 187 | 85 | 6 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-06 | 188 | 85 | 6 | 524d1d928c9386acf20e53d31894107dd7290dc7 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-06 | 188 | 85 | 6 | 1b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-06 | 188 | 85 | 6 | cd2d1f8e43c252dd8730a5758458ef63e7ffc836 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-06 | 188 | 85 | 6 | f5a2f324f3f6c5078d57130392d3f1ba74f29094 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-06 | 188 | 85 | 6 | 7191087d8754f5e8700e3d744cd920ee26db1e57 | |
| ToppCell | 5'-Airway_Nasal-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-06 | 188 | 85 | 6 | 6c9d5e4014f807149328ff4eabd5e86dfe18094d | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.69e-06 | 189 | 85 | 6 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 190 | 85 | 6 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-06 | 190 | 85 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 190 | 85 | 6 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-06 | 191 | 85 | 6 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.79e-06 | 191 | 85 | 6 | 44a9a6768084dafc641ad455b65862bfd4cc0cb9 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.79e-06 | 191 | 85 | 6 | 094c9d3270fc1e487ccf10fb4936af5f081f6009 | |
| ToppCell | facs-Lung-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.79e-06 | 191 | 85 | 6 | ba02cbdfda6a94374a6472eb88499059979af472 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-06 | 191 | 85 | 6 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-06 | 191 | 85 | 6 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.79e-06 | 191 | 85 | 6 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-06 | 192 | 85 | 6 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 192 | 85 | 6 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 192 | 85 | 6 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-06 | 192 | 85 | 6 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 192 | 85 | 6 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 192 | 85 | 6 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 192 | 85 | 6 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 192 | 85 | 6 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 192 | 85 | 6 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | 15-Trachea-Endothelial-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 1.90e-06 | 193 | 85 | 6 | 6ea0444fc3dc156997129387184e6418947f4b12 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-06 | 193 | 85 | 6 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-06 | 193 | 85 | 6 | daefbfd3a3dd1351fbe94b9abfd807db44d56c24 | |
| ToppCell | 15-Trachea-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 1.90e-06 | 193 | 85 | 6 | b1ebf8df2d55e2938e5a495ea68b80c4ac216dc0 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.90e-06 | 193 | 85 | 6 | 68089ba4123e2f9bea9aae0023a844b5a57bfc0e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-06 | 194 | 85 | 6 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-06 | 194 | 85 | 6 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-06 | 195 | 85 | 6 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.02e-06 | 195 | 85 | 6 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.02e-06 | 195 | 85 | 6 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-06 | 195 | 85 | 6 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 196 | 85 | 6 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-06 | 196 | 85 | 6 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 196 | 85 | 6 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 196 | 85 | 6 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 196 | 85 | 6 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 196 | 85 | 6 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 196 | 85 | 6 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 196 | 85 | 6 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 196 | 85 | 6 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.14e-06 | 197 | 85 | 6 | 4e58bbf3ecb30b4c8199adcc04d2eb134d90de56 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-06 | 197 | 85 | 6 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-06 | 197 | 85 | 6 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-06 | 197 | 85 | 6 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.21e-06 | 198 | 85 | 6 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.21e-06 | 198 | 85 | 6 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-06 | 199 | 85 | 6 | 84545ced0c792bc77980a50d65e484eab648d47e | |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|metastatic_Brain / Location, Cell class and cell subclass | 2.27e-06 | 199 | 85 | 6 | 12133087eae9f0e9b6c13a71e8187117768e64ce | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-06 | 199 | 85 | 6 | edba1833ef5c4ca122d7c32f97670314e005f93b | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.27e-06 | 199 | 85 | 6 | 1c69395c9305b6ecb0a826d46c8e8ec95795ad6d | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-06 | 199 | 85 | 6 | 6a2943a23fdd2ec814662db7c21a0d6804a6cbbc | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-06 | 199 | 85 | 6 | e78f661b40da34768469549b6e755d330be6bbd8 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-06 | 200 | 85 | 6 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-06 | 200 | 85 | 6 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.34e-06 | 200 | 85 | 6 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| Computational | Adhesion molecules. | 5.20e-07 | 141 | 55 | 8 | MODULE_122 | |
| Computational | Neighborhood of CDH11 | 2.69e-04 | 25 | 55 | 3 | GNF2_CDH11 | |
| Computational | Placenta genes. | 5.13e-04 | 463 | 55 | 9 | MODULE_38 | |
| Computational | Neighborhood of EGFR | 5.66e-04 | 32 | 55 | 3 | GNF2_EGFR | |
| Computational | DRG (dorsal root ganglia) genes. | 6.90e-04 | 384 | 55 | 8 | MODULE_2 | |
| Drug | LMWH | COL7A1 ERBB4 VWF FN1 POLR2A POLR2B LRP1 LAMB1 LAMB2 PAPPA CFP POLN ADAM12 | 1.04e-06 | 663 | 85 | 13 | CID000000772 |
| Drug | kalinin | 1.93e-06 | 55 | 85 | 5 | CID000032518 | |
| Drug | AC1L9INI | 2.75e-06 | 59 | 85 | 5 | CID000445839 | |
| Drug | monatepil | 4.00e-06 | 29 | 85 | 4 | CID000060810 | |
| Drug | BM165 | 8.11e-06 | 11 | 85 | 3 | CID003352881 | |
| Drug | Levodopa [59-92-7]; Up 200; 20.2uM; PC3; HT_HG-U133A | 9.73e-06 | 199 | 85 | 7 | 4571_UP | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 1.49e-05 | 83 | 85 | 5 | CID011968896 | |
| Drug | Grgds | 1.49e-05 | 83 | 85 | 5 | CID000123811 | |
| Drug | Sas 1 | 2.72e-05 | 16 | 85 | 3 | CID006328170 | |
| Drug | Rgd Peptide | 3.17e-05 | 239 | 85 | 7 | CID000104802 | |
| Drug | B-08 | 4.12e-05 | 3 | 85 | 2 | CID016086421 | |
| Drug | DB04780 | 4.26e-05 | 170 | 85 | 6 | CID005459389 | |
| Drug | desmosine | 4.61e-05 | 53 | 85 | 4 | CID000025435 | |
| Drug | ALT-711 | 6.36e-05 | 21 | 85 | 3 | CID000216304 | |
| Disease | cerebral palsy (implicated_via_orthology) | 1.04e-08 | 10 | 80 | 4 | DOID:1969 (implicated_via_orthology) | |
| Disease | connective tissue disease (implicated_via_orthology) | 1.92e-08 | 3 | 80 | 3 | DOID:65 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | COL7A1 PDE2A ERBB4 VWF FN1 WDR88 OTOGL EIF4A2 KBTBD8 TENM1 CFP ADAM12 NIPBL NOTCH1 SORL1 | 1.71e-07 | 1074 | 80 | 15 | C0006142 |
| Disease | cortical thickness | THSD4 FBN1 FBN2 PMPCA ADAMTS2 ADAMTS7 ADAMTS9 LRP1 LRP4 ADAMTS20 ADAM12 AGAP1 STAB1 | 8.81e-06 | 1113 | 80 | 13 | EFO_0004840 |
| Disease | scoliosis (is_implicated_in) | 4.34e-05 | 4 | 80 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | spontaneous coronary artery dissection | 8.17e-05 | 31 | 80 | 3 | EFO_0010820 | |
| Disease | disease recurrence, unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 9.87e-05 | 33 | 80 | 3 | EFO_0003761, EFO_0004952, EFO_0008343, MONDO_0004985, MONDO_0005090 | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 2.01e-04 | 8 | 80 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | cortical surface area measurement | THSD4 ADAMTSL1 FBN1 FBN2 PMPCA ADAMTS7 ADAMTS9 ADAMTS20 PAPPA ADAM12 FBN3 AGAP1 | 2.62e-04 | 1345 | 80 | 12 | EFO_0010736 |
| Disease | aortic aneurysm | 3.22e-04 | 10 | 80 | 2 | EFO_0001666 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 4.08e-04 | 53 | 80 | 3 | C4707243 | |
| Disease | intraocular pressure measurement | 4.68e-04 | 509 | 80 | 7 | EFO_0004695 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 5.05e-04 | 57 | 80 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | aortic measurement | 6.12e-04 | 251 | 80 | 5 | EFO_0020865 | |
| Disease | serum dimethylarginine measurement | 6.78e-04 | 63 | 80 | 3 | EFO_0005418 | |
| Disease | brain measurement, neuroimaging measurement | 7.39e-04 | 550 | 80 | 7 | EFO_0004346, EFO_0004464 | |
| Disease | Proteinuria | 7.45e-04 | 15 | 80 | 2 | HP_0000093 | |
| Disease | migraine disorder, endometriosis | 1.04e-03 | 73 | 80 | 3 | EFO_0001065, MONDO_0005277 | |
| Disease | unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 1.17e-03 | 76 | 80 | 3 | EFO_0003761, EFO_0008343, MONDO_0004985, MONDO_0005090 | |
| Disease | carotid artery disease (is_marker_for) | 1.20e-03 | 19 | 80 | 2 | DOID:3407 (is_marker_for) | |
| Disease | taurocholate measurement | 1.34e-03 | 20 | 80 | 2 | EFO_0010538 | |
| Disease | carotid artery intima media thickness | 1.41e-03 | 450 | 80 | 6 | EFO_0007117 | |
| Disease | X-12063 measurement | 1.66e-03 | 186 | 80 | 4 | EFO_0021283 | |
| Disease | waist-hip ratio | MEP1A THSD4 ERBB4 ZMYND11 FN1 ADAMTS2 ADAMTS9 ADAMTS20 LAMB1 STAB1 | 1.74e-03 | 1226 | 80 | 10 | EFO_0004343 |
| Disease | macula measurement | 1.76e-03 | 189 | 80 | 4 | EFO_0008375 | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 1.77e-03 | 23 | 80 | 2 | EFO_0004286, EFO_0004791 | |
| Disease | descending aortic diameter | 1.78e-03 | 88 | 80 | 3 | EFO_0021788 | |
| Disease | refractive error, age at onset, Myopia | 1.90e-03 | 193 | 80 | 4 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | Myasthenic Syndromes, Congenital | 1.93e-03 | 24 | 80 | 2 | C0751882 | |
| Disease | ulcerative colitis | 2.20e-03 | 335 | 80 | 5 | EFO_0000729 | |
| Disease | response to angiotensin-converting enzyme inhibitor, response to angiotensin receptor blocker, angioedema | 2.26e-03 | 26 | 80 | 2 | EFO_0005325, EFO_0005532, EFO_0010735 | |
| Disease | Abnormality of refraction | 2.34e-03 | 673 | 80 | 7 | HP_0000539 | |
| Disease | triacylglycerol 54:7 measurement | 2.62e-03 | 28 | 80 | 2 | EFO_0010425 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SIQNMRGNAHCVDCE | 446 | Q96P64 | |
| RKAENCTAEGMVCNH | 491 | Q15303 | |
| RNMRGNSHCVDCETQ | 616 | Q9UPQ3 | |
| IEGVDSNMCCGTHVS | 201 | Q9BTE6 | |
| FGMNHDTLDRGCSCQ | 356 | O43184 | |
| DHNECATSTMCVNGV | 531 | Q75N90 | |
| QQIQSVCMECQGHGE | 171 | P31689 | |
| QNHRNVGMACSICGC | 131 | Q16581 | |
| HLMGEAGCRSCPNNS | 1466 | Q96F81 | |
| VAAACSQAECMGGSQ | 516 | Q5T6C5 | |
| TETHDICVQGQCMAA | 681 | P59510 | |
| ICVQGQCMAAGCDHV | 686 | P59510 | |
| QCMAAGCDHVLNSSA | 691 | P59510 | |
| TCGHGYQMRDVKCVN | 1091 | P59510 | |
| CSQTCGRTGMQVRSV | 926 | O95450 | |
| SRSCGMGVQSAERQC | 551 | Q9UKP4 | |
| EGQRHCCGVAQMREH | 116 | O00170 | |
| CCGVAQMREHSSLGH | 121 | O00170 | |
| SIQNMRGNAHCVDCE | 446 | Q5VW22 | |
| IAQCHQTGCVVSIMG | 726 | Q7Z5Q5 | |
| IEKDGGCNHMVCRNQ | 351 | Q9Y4X5 | |
| RVIHNASIMNAVGCC | 106 | Q9H2P9 | |
| AANALCAGMRVTGCN | 246 | Q8WWA0 | |
| TGSMCNINIDECAGN | 671 | P46531 | |
| DVSKHLCMINNGGCS | 3271 | Q9NZR2 | |
| REAQMIFLNCGHVCC | 681 | Q6UWE0 | |
| GQRACACAHGMLAED | 2176 | Q07954 | |
| THAVNGCCGLQMIAL | 21 | Q8N7Q2 | |
| MCISGLCQIVGCDHQ | 151 | Q8N6G6 | |
| MGQACGHSILCRSQQ | 1 | O00408 | |
| GMTVVQHCVSCLGAV | 2081 | Q6KC79 | |
| NVSGGVCDDCQHNTM | 356 | P07942 | |
| EGTGQCHCRQHMVGR | 536 | P55268 | |
| VTCGLGQTMEQRTCN | 271 | P27918 | |
| ALRHMVLENCCGSAG | 301 | Q8N628 | |
| GSFHVCQEMQGQCSV | 1466 | Q13219 | |
| IAGTCGNHQRMFTVE | 486 | Q8NFY9 | |
| TGIKHDGTMCDTCRQ | 76 | Q86YT6 | |
| SVTCGQGRATRQVMC | 1251 | Q9P2N4 | |
| SLTARVCHMGVCQGQ | 221 | Q6PRD7 | |
| VAHAGCMIGNSSCGV | 291 | Q9Y223 | |
| MRACNSAGCGNETAQ | 1551 | Q8TD84 | |
| RQQCTCHAGKGMVCQ | 1606 | Q9Y6R7 | |
| EEGHMLNCTCFGQGR | 536 | P02751 | |
| IQHCNIRCMNGGSCS | 116 | P35555 | |
| CAVQGGVCVNLTHMD | 106 | Q86WU2 | |
| CINCMVAVGHGSDLR | 556 | Q96C10 | |
| SIQNMRGNAHCVDCE | 446 | Q5VUJ5 | |
| TCHACIGGTNVRNEM | 131 | Q14240 | |
| ATCDANSVMNCGIRG | 51 | Q86SG7 | |
| LCTQGCELHEGRNHM | 86 | Q8NAJ2 | |
| RGFVRQEMSQHCACQ | 2791 | Q02388 | |
| IQQCSVRCMNGGTCA | 146 | P35556 | |
| GICMNGHCINSEGSF | 666 | P35556 | |
| CAVGGVQCQTMTVNR | 146 | Q96RP9 | |
| AGGVNCETTCANLAM | 861 | Q3ZCN5 | |
| MCVGCGSQIHDQFIL | 26 | Q96A47 | |
| RAHTMCIEGSQGCEN | 126 | Q9UJJ7 | |
| HGGICDCQTSRDTTM | 136 | Q10713 | |
| FHSMVCDGIIQCRDG | 1291 | Q92673 | |
| NSCIVCNMGHSNTEI | 471 | Q96HN2 | |
| VNVKGMASCRCISGH | 686 | Q16819 | |
| VHVCNLCGIMAIANT | 1116 | P30876 | |
| QCVGFCHGVLNTDNM | 326 | Q9BVL4 | |
| IMGNGHQRSVACTNC | 1171 | Q9UKZ4 | |
| QRTEGCDHMTCSQCN | 431 | Q8TC41 | |
| CHQCTSLMVGLIRQG | 1026 | Q5VT25 | |
| TMVCNRHCENGGQCL | 1391 | Q8N2E2 | |
| VIIMATNCENCGHRT | 281 | O75312 | |
| VGARSGCVNMCEQAL | 916 | Q5T7W0 | |
| EFRNCGACVTLMQGH | 306 | Q6ZMY6 | |
| HINEMCQERCVDGCS | 316 | P04275 | |
| VCHQSGEVSMGSFCR | 281 | Q8WVR3 | |
| SEQECMSSCQGSLHG | 796 | O95428 | |
| ERTGRCQTCAGNMTE | 66 | P24928 | |
| CGPGMQLSADRHSCQ | 166 | Q96DN2 | |
| GCSEHANCSQVGTMV | 2101 | Q9NY15 | |
| SGVMHQECQIQSCEL | 86 | Q1RN00 | |
| NVTHSRMQICDQCGK | 456 | Q9UFB7 | |
| ICSVCRDHMAQHFNG | 526 | Q9Y5L0 | |
| HNVCELCVNQTSGGM | 466 | Q6PKC3 | |
| NGQSEVAAHACASMC | 406 | A7E2V4 | |
| QTTNDGVCQSMCHDK | 456 | Q15326 | |
| SECSKTCGLGMQHRQ | 686 | Q6ZMP0 | |
| GAGVRTRSVVCMTNH | 811 | Q6ZMP0 | |
| MVRQFQGHTDGASCI | 581 | Q04725 | |
| SHQGRGTMFECETCR | 951 | P15822 | |
| MVICCAAVNCSNRQG | 1 | Q8WY91 | |
| NMNIRGDTGHKACEC | 136 | Q8NDP4 | |
| MVRGAVQCTCHTGYR | 371 | O75096 | |
| ITRGQLMNCHLCAGV | 356 | Q96BF6 | |
| VQSQMCGDCHRVEAK | 136 | Q96D46 |